Treatment with a Chimeric CD4 Monoclonal Antibody is Associated with a Relative Loss of CD4+/CD45RA+Cells in Patients with Rheumatoid Arthritis - Concepedia

Concepedia

Publication | Closed Access

Treatment with a Chimeric CD4 Monoclonal Antibody is Associated with a Relative Loss of CD4+/CD45RA+Cells in Patients with Rheumatoid Arthritis

20

Citations

30

References

1997

Year

Peter A. Van Der Lubbe, F. C. Breedveld, Paul P. Tak, A. Schantz, James N. Woody, A. M. M. Miltenburg

Journal of Autoimmunity

Rheumatoid DisorderRheumatologyAutoimmune DiseaseRheumatic DiseasesImmunologyAutoimmunityPaediatric RheumatologyInflammatory Rheumatic DiseaseImmunologic DiseaseImmunotherapyMedicineRelative LossRheumatoid Arthritis

References

	Year	Citations

Page 1

Page 1